LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 29.92 | 84.90 | 2245 | 2237 | 1.0033 | 1.0014 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 29.92 | 84.90 | 2133 | 2237 | 0.9532 | 0.9798 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 29.92 | 84.90 | 2205 | 2237 | 0.9854 | 0.9938 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 31.62 | 84.90 | 55 | 2449 | 0.0225 | -0.0856 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 31.62 | 84.90 | 2435 | 2449 | 0.9940 | 0.9975 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 31.62 | 84.90 | 2303 | 2449 | 0.9401 | 0.9747 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 31.62 | 84.90 | 2392 | 2449 | 0.9764 | 0.9902 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 33.32 | 84.90 | 92 | 2722 | 0.0338 | 0.0162 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 33.32 | 84.90 | 2643 | 2722 | 0.9708 | 0.9882 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 33.32 | 84.90 | 2524 | 2722 | 0.9271 | 0.9700 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 33.32 | 84.90 | 2591 | 2722 | 0.9517 | 0.9803 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 35.03 | 84.90 | 123 | 2991 | 0.0411 | 0.0748 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 35.03 | 84.90 | 2826 | 2991 | 0.9447 | 0.9780 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 35.03 | 84.90 | 2726 | 2991 | 0.9113 | 0.9642 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 35.03 | 84.90 | 2796 | 2991 | 0.9347 | 0.9739 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 36.73 | 84.90 | 132 | 3254 | 0.0406 | 0.0875 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 36.73 | 84.90 | 3077 | 3254 | 0.9455 | 0.9788 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 36.73 | 84.90 | 3018 | 3254 | 0.9274 | 0.9715 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 36.73 | 84.90 | 3078 | 3254 | 0.9458 | 0.9789 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 38.43 | 84.90 | 156 | 3459 | 0.0451 | 0.1205 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 38.43 | 84.90 | 3296 | 3459 | 0.9527 | 0.9820 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 38.43 | 84.90 | 3221 | 3459 | 0.9310 | 0.9735 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 38.43 | 84.90 | 3280 | 3459 | 0.9481 | 0.9802 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 40.14 | 84.90 | 199 | 3682 | 0.0540 | 0.1696 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 40.14 | 84.90 | 3557 | 3682 | 0.9660 | 0.9873 | MN20160318_Q02 | F15 |